Student Reviews of Axel Anderson Professor at Georgetown U
Courses are taught by faculty who are well-respected practitioners and leaders in clinical and translational inquiry.
Programme Administration
Teaching Faculty
Jason G. Umans, MD, PhD
Jason Chiliad. Umans, MD, PhD is an Associate Professor of Medicine and of Obstetrics and Gynecology at Georgetown Academy. He is Scientific Director of the Biomarker, Biochemistry, and Biorepository Core and of the Field Studies Division and Phoenix Field Role at MedStar Wellness Research Institute (MHRI). He directs the Translational Workforce and Mentored Career Evolution (KL2) programs in the Georgetown-Howard Universities Heart for Clinical and Translational Science (GHUCCTS) and is co-director of the pre- and post-doctoral (TL1) training programs. As an experienced clinical and translational investigator, Dr. Umans is committed to multidisciplinary team science.
His enquiry has been continuously supported past NIH and non-profit sponsors for approximately xxx years. His delivery to training and nurturing the next generation of researchers include his cosmos of the MedStar Research Scholars Program, his GHUCCTS training activities, his service as Director of Graduate Studies for the MS program in Clinical and Translational Research at Georgetown, his leadership of GHUCCTS programs for mentor training, along with leadership roles in the national CTSA training program and his own mentorship of postdoctoral and junior faculty colleagues from multiple disciplines. His NIH-supported research is currently focused on genetic, lifestyle, and environmental mechanisms contributing to cardiovascular disease and health disparities in Native populations.
Dr. Umans has been board-certified in internal medicine, nephrology, clinical pharmacology, and as a clinical hypertension specialist. He is internationally recognized as an skilful in medical disorders during pregnancy, particularly hypertension, diabetes, and kidney illness. He has published more than than 200 peer-reviewed articles, on topics including vascular biology, pharmacokinetic modeling, drug assay development, obstetric and fetal pharmacology, neuropharmacology, vascular and renal physiology, hemodynamic regulation, inflammatory mechanisms, diabetes, kidney, and cardiovascular disease and health disparities. He also has written volume chapters and review articles, and has spoken widely on clinical pharmacology, hypertension, diabetes, and renal affliction in pregnancy, and on cardiovascular illness, pharmacotherapy, and health disparities. Dr. Umans received his PhD in Pharmacology and Biomathematics besides as his Dr. from Cornell University. He completed a residency in medicine and a fellowship in nephrology at the University of Chicago.
Irene A. Jillson, PhD
Irene A. Jillson, PhD is an Assistant Professor, and teaches in the School of Nursing and Health Studies (NHS), Schoolhouse of Medicine and the School of Foreign Service. She has designed and launched courses in global health ethics, global health systems and politics and global health enquiry. She as well teaches medical ethics, graduate and undergraduate health inquiry, and medico office and behavior. Dr. Jillson, who has a PhD in technology policy and management from Westminster Academy, was founder and President of Policy Research Incorporated, a individual inquiry firm that carried out local, national, and international health and social policy research studies for more than 25 years.
Nawar Thousand. Shara, PhD
Nawar M. Shara, PhD is an Associate Professor of Medicine and the Manager of the Department of Biostatistics and Biomedical Informatics, MedStar Wellness Enquiry Institute (MHRI)
Dr. Shara is an established, NIH-funded, clinical investigator with many years of experience in report design, predictive modeling, missing data imputation techniques, health services research, Big Data solutions, take chances prediction models and cohort studies. In her role as the CTSA biostatistics, epidemiology and research design (BERD) Manager, she has created mechanisms that facilitated biostatistical and information management support that enabled hundreds of clinical and translational research collaborations many of which lead to funding.
Dr. Shara regularly engages in teaching and education across the different MedStar entities and developed several curriculums for pedagogy biostatistics to clinicians and health care providers
Shaunagh Browning, DNP, MS, RN, FNP-BC
Bio Coming Soon!
One thousand. Scott Harris, MD, MS, FACP, AGAF
Dr. Scott Harris is an independent drug development consultant and co-founder and Chief Medical Officeholder of Lyric Pharmaceuticals, a venture-backed biotech defended to gastrointestinal therapies for disquisitional illness. He is an Adjunct Professor of Medicine at Georgetown Academy Medical School. He is also Chief of Middleburg Consultants, a consulting firm specializing in gastrointestinal pharmaceutical evolution. Dr. Harris has led studies and programs in the US and rest-of-globe. From 2012-2015, he served equally Chief Medical Officer of Avaxia Biologics, and in 2011, interim Chief Medical Officeholder of Tranzyme Pharmaceuticals, where he was medical lead for the company'south successful IPO. From 2008-2010, he served every bit Chief Medical Officer of Ocera Therapeutics. From 2006-2008, he was Master Medical Officer and Vice President of Clinical Affairs at Napo Pharmaceuticals, where he co-authored the two-stage pivotal adaptive trial blueprint leading to approval of Mytesi™ (crofelemer) for HIV-associated diarrhea. He oversaw trials in Southeast Asia for handling of cholera. He has served on the faculties of the Medical College of Wisconsin, where he conducted basic research in diarrhea, and the University of Wisconsin in Milwaukee, where he was Clinical Professor and Head of the Division of Gastroenterology. He has been a consultant on 3rd-world drug development for the Bill and Melinda Gates Foundation and PATH. Dr. Harris is also a member of the Executive Board of the Center for Diagnostics and Therapeutics of the American Gastroenterological Association and an ad hoc member of the Division of Gastrointestinal and Inborn Errors Products Advisory Committee.
Pravin Chaturvedi, PhD
Pravin Chaturvedi, PhD is an experienced drug programmer and biotech entrepreneur. He is the Chairman of the Scientific Informational Board for Napo Pharmaceuticals and as well serves every bit the CEO and Manager for IndUS and Oceanyx Pharmaceuticals, both of which he also co-founded. Previously, he has served as the President and CEO of Pivot Pharmaceuticals and Scion Pharmaceuticals. Prior to his office at Scion, he was the Caput of Atomic number 82 Evaluation at Vertex and was in Production Development groups at Alkermes and Parke-Davis/Warner-Lambert (Pfizer). Over his career; he has participated in the successful development of several new drugs for the treatment of CNS, viral and gastrointestinal disorders. In addition to the boards of IndUS and Oceanyx, Dr. Chaturvedi is also the Chairman of the Board of Cellanyx, a first-in-class alive tumor biopsy phenotypic testing enterprise. He also serves as a board fellow member for Fuel Ed Schools and Sindu Research Laboratories. He has previously served on the boards of Pin, Scion, Bach Pharma, PRADAN USA, Sindu Pharmaceuticals, and Tie Boston. He as well serves on several advisory boards including Enlivity and Mag Optics and is an adjunct kinesthesia member at Georgetown Medical School. He holds a PhD from West Virginia University and received his Available'due south in Chemist's shop from the University of Bombay.
Jon Fryzek, PhD
Bio Coming Before long!
Kimberly Henderson, PhD
Kimberly Henderson, PhD is an Associate with Booz Allen Hamilton where she specializes in the areas of health, health disparities, and strategic communications. Prior to joining Booz Allen Hamilton, she was the Wellness Program Director in the Office of Policy and Planning at the University Of Maryland Schoolhouse Of Medicine and a Inquiry Acquaintance in the Division of Cardiology. She conducted health disparities research studies that focused on using Customs-Based Participatory Research (CBPR), advice and health promotion strategies and improving the quality of wellness of minority and underserved populations throughout the state of Maryland. She also served every bit the program manager and Co-Investigator for grants that totaled over $5 million at the academy.
Dr. Henderson received her B.A. in Mass Communications from Dillard University, M.A. in Journalism from the University of Arkansas, Fayetteville and PhD in Mass Communications with a Health Advice focus from Howard University. Her research interests include agreement the role of media in a person's health decisions, using forms of media to assistance in behavior change and the apply of health communication to reduce health disparities. Dr. Henderson is an Adjunct Assistant Professor at Georgetown University.
Industry Speakers
Keith Anderson, PhD
Senior Vice President, Technical Operations, Sierra Oncology
Noel J. Cusack, MSc, PhD, MRSC
Independent Consultant, Nonclinical Evolution, Talaris Advisors, LLC
Carolyn Finkle, MSc
Vice President, Regulatory Affairs, Karyopharm
Joyce James, PhD
Francisco Leon, MD, PhD
Jeffrey Murray, Md, MPH
Source: https://ctsa.georgetown.edu/faculty/
0 Response to "Student Reviews of Axel Anderson Professor at Georgetown U"
Post a Comment